In NRC1, we observed upregulation of RIPK3 (Fig. 5A), EMT activity (Additional file 3: Fig. S3A and S3D), and enrichment of advanced stages (15.60%; Fig. 2E), suggesting that RIPK3 may play an indispensable role in CRC progression. The gene discussed is RIPK3; the disease is colorectal carcinoma.